View Source

Click here to return to main plasmids page
Click here to return to main plasmids page
Papillomaviruses	Paper Name	Reference	Lab Name	Distribute?	Resistance	Notes
BPV1	pSheLL	[1]	pXL∫	AddGene.org	kan	Bicistronic, too large to self-package*

BPV3		unpublished	#2903	yes, contact Martin Müller	amp	Bicistronic. Titer of BPV3 is very poor

BPV8		unpublished	#2762	yes, contact Martin Müller	amp	Bicistronic codon-modified L1/L2 expression plasmid

CRPV	pCRPVsheLL	[2]	p¢LLw	AddGene.org	amp	Bicistronic, too large to self-package*

HPV1	p1sheLL	unpublished	p1LLw	not yet	amp	HPV1 gives poor L1 yield and HPV1 pseudovirus is poorly infectious

HPV2	p2sheLL	unpublished	p2LLw	yes	amp	This plasmid produces good yields of HPV2 prototype L1/L2 particles that have essentially no detectable infectivity on any tested cell line.
	pRaL1	[3] [4]	pRäLw			This variant (EF362755) HPV2 L1 produces pseudoviruses with detectable (but still extremely poor) infectious titer. Harvest 72h post-transfection
	paL2	[3]	pä∫			HPV2 L2 expression plasmid
HPV3	p3sheLL	[5]		Faust et al	amp	Bicistronic codon-modified L1/L2 expression plasmid. Pseudovirions are poorly infectious
HPV5	p5sheLL	[6]	p5LLw	AddGene.org	amp	Bicistronic, too large to self-package*. HPV5 has high particle to infectivity ratio on many cell types

HPV6	p6sheLLr †	[7]	p6LLw2	AddGene.org	amp	† orignal "p6sheLL" had an unexpected duplication in the backbone due to a cloning error. The duplication was repaired in p6sheLLr. p6sheLL and p6sheLLr give essentially identical titer yields for HPV6 pseudovirus production.

HPV11	p11L1w	[8]	p11Lw	AddGene.org	kan	Titer of HPV11 pseudovirus is very poor. Requires Müller MTA.
	p11L2w	[9]	p11∫w	AddGene.org	kan
HPV15	p15sheLL	[5]		Faust et al	amp	Bicistronic codon-modified L1/L2 expression plasmid. Pseudovirions are poorly infectious
HPV16	p16sheLL	[6, 10]	p16LLw	AddGene.org	amp	Replaces pXuLL. Bicistronic, too large to self-package*. Requires Müller MTA.
	p16L1L2	[11, 12]	phüL∫, frankenvirus	AddGene.org	zeo	Synthetic HPV capable of self-packaging. Suitable for infectious amplification in 293TT cells. This plasmid is prone to collapse*

HPV18	p18sheLL	[2, 13]	p18LLw	AddGene.org	amp	Bicistronic, too large to self-package*

HPV27	Senger et al	[3]

HPV31	p31sheLL	[2, 14]	p31LLw	AddGene.org	amp	Bicistronic, too large to self-package*. Requires Kanda MTA.
HPV32	p32sheLL	[5]		Faust et al	amp	Bicistronic codon-modified L1/L2 expression plasmid
HPV33	p33sheLL	[5]		Faust et al	amp	Bicistronic codon-modified L1/L2 expression plasmid
HPV35	p35sheLL	[15]	5psh35F	AddGene.org	amp	HPV35 L1 and L2 genes codon optimised for mammalian expression. Requires HPA UK MTA

HPV38	p38sheLL	[16]		Faust et al

HPV39	p39sheLL	[15]	39pshC	AddGene.org	amp	HPV35 L1 and L2 genes codon optimised for mammalian expression. Requires HPA UK MTA (Simon Beddows)

HPV45	p45sheLL	[2, 6]	p45LLw	AddGene.org	amp	Bicistronic, too large to self-package*

HPV52	p52sheLL	[17]	p52LLw	AddGene.org	amp	Bicistronic, too large to self-package*. Poor titer yield. Requires Kanda MTA.

HPV56	#3123	unpublished	#3123	yes, contact Martin Müller	amp	Bicistronic codon-modified L1/L2 expression plasmid

HPV57	Senger et al	[3]		Senger et al

HPV58	p58sheLL	[14]	p58LLw	AddGene.org	amp	Bicistronic, too large to self-package*. Requires Kanda MTA.

HPV59	p59sheLL	[15]	59pshB	yes, contact Simon Beddows	amp	HPV35 L1 and L2 genes codon optimised for mammalian expression. Requires HPA UK MTA

HPV68	#2687	unpublished	#2687	yes, contact Martin Müller	amp	Bicistronic codon-modified L1/L2 expression plasmid
HPV68	p68sheLL	[5]		Faust et al	amp	Bicistronic codon-modified L1/L2 expression plasmid
HPV73	#3122	unpublished	#3122	yes, contact Martin Müller	amp	Bicistronic codon-modified L1/L2 expression plasmid
HPV76	p76sheLL	[5]		Faust et al	amp	Bicistronic codon-modified L1/L2 expression plasmid
HPVs 6, 8, 11, 18, 26, 31, 33, 34, 35, 38, 29, 40, 42, 43, 44, 51, 52, 53, 56, 59, 66, 68, 70, 73	pVITRO-X-L1L2	[18]		AddGene.org	kan	Roden and Kirnbauer labs

MusPV1	pMuSheLL	[19]	pMuLLw	AddGene.org	amp	Mammalian expression plasmid with codon modified L1 and L2 genes of Mus musculus papillomavirus type 1*
	pMusPV	[20-22]	pMusPV	AddGene.org	zeo	Synthetic Mus musculus papillomavirus type 1 clone

Polyomaviruses
BKV-I	pCAG-BKV	[23]		Nakanishi et al		VP1/2/3 packaging plasmid for BKV serogroup I (isolate KOM5) reporter vectors
	pBKV-Ia	[24]	pIaw	yes	zeo	Codon modified BKV genotype Ia VP1 expression plasmid

BKV-IV	pwB	[25]	pwB	yes	zeo	VP1 based on BKV serogroup IV isolate A-66H [26]
	pwB2b	[25]	pwB2b	AddGene.org	zeo	BKV-IV VP1/VP2 dual expression plasmid
	pwB3b	[25]	pwB3b	AddGene.org	zeo	BKV-IV VP1/VP3 dual expression plasmid
	ph2b	[25]	ph2b	AddGene.org	zeo	BKV-IV VP2 expression plasmid
	ph3b	[25]	ph3b	AddGene.org	zeo	BKV-IV VP3 expression plasmid
BKV variants	Variants	[24]	various	Yes	zeo	Codon modified VP1 ORFs from various BKV genotypes

HPyV6	pHPyV6-607a	[27]	pe1D	AddGene.org	zeo	Reference clone of human polyomavirus 6
	p6VP1	[27]	pe1VP1	AddGene.org	zeo	Human polyomavirus 6 VP1 expression construct

HPyV7	pHPyV7-713a	[27]	pe2S	AddGene.org	zeo	Reference clone of human polyomavirus 7
	p7VP1	[27]	pe2VP1	AddGene.org	zeo	Human polyomavirus 7 VP1 expression construct

HPyV10	p10ww	[28, 29]	p10ww	yes	zeo	Reference clone of human polyomavirus 10 (MWPyV)
	pVP1Xw	Unpublished	pVP1Xw	not yet	zeo	HPyV10 VP1 mammalian expression (codon modified)
	pVP2Xh	Unpublished	pVP2Xh	not yet	zeo	HPyV10 VP2 mammalian expression (codon modified)
	pVP3Xh	Unpublished	pVP3Xh	not yet	zeo	HPyV10 VP3 mammalian expression (codon modified)
	pVP1Xm	Unpublished	pVP1Xm	not yet	zeo	HPyV10 VP1 fused to MBP (bacterial expression)

JCV	p2A	[36]	p2Aw	not yet	zeo	Codon-modified JCV-2A (wt) VP1 expression plasmid
	p3B	[36]	p3Brw	not yet	zeo	Codon-modified JCV-3B (wt) VP1 expression plasmid
	pJC_VP1-pwP	[30]	p1Aw	Atwood Lab	zeo	Codon-modified JCV-Mad1 (genotype 1A) VP1 expression plasmid
	p5147w	[36]	p5053w	not yet	zeo	Inferred wt VP1 sequence of PML patients 5053, 5147, 5228
	p5147m	[36]	p5228m	not yet	zeo	PML-mutant VP1 sequence from CSF of PML patient 5147, 5228
	pJCV-VP2	[36]	ph2j	not yet	zeo	Codon-modified JCV consensus VP2 expression plasmid
	pJCV-VP3	[36]	ph3j	not yet	zeo	Codon-modified JCV consensus VP3 expression plasmid

MCV	pMCV-R17a	[27]	pMCV-L	AddGene.org	kan	Wild-type MCV from healthy skin
	pMCV-R17b	[27]	p17A	yes	zeo	MCV w.t. reference clone. Replicates a bit better than R71a [31]
	pMCV-16b	unpublished	p16A	yes	zeo	MCV–R17a chimera with NCRR of Asian isolate MCV-16b
	pwM	[32]	pwM	AddGene.org	zeo	Merkel cell polyomavirus (MCV) VP1 expression construct
	ph2m	[32]	ph2m	AddGene.org	zeo	MCV VP2 expression construct
	pwM2m	[33]	pwM2m	yes	zeo	MCV VP1/VP2 dual expression (VP2 expression relatively weak)
	pMmw	[34]	pMmw	yes	amp	MCV VP1/VP2 expression, too big to self-package*
	p2mw	[34]	P2mw	yes	amp or blast	MCV VP2, CMV promoter, non-replicating. Too big to package
	pCM	[34]	pCM	yes	amp	MCV VP1 expression, CMV promoter. Too big to package

MPyV	pwP	[32]	pwP	AddGene.org	zeo	Mouse polyomavirus (MPyV) VP1 expression construct
	ph2p	[32]	ph2p	AddGene.org	zeo	MPyV VP2 expression construct
	ph3p	[32]	ph3p	AddGene.org	zeo	MPyV VP3 expression construct

BoPyV	pBoPyV1-S22	[35]	pFF-S5BPyV1clonex	AddGene.org	zeo	Re-ligatable bovine polyomavirus 1 isolate 1S22
	pBoPyV2a-S22	[35]	pFF-S11BPyV2aclone2	AddGene.org	zeo	Re-ligatable bovine polyomavirus 2a isolate 2aS22
	pBoPyV2b-S24	[35]	pFF-S5BPyV2bcloneq	AddGene.org	zeo	Re-ligatable bovine polyomavirus 2b isolate 2bS24
	pBoPyV3-S22	[35]	pFF-BPyV3clone1	AddGene.org	zeo	Re-ligatable bovine polyomavirus 3 isolate 3S22
	pBoPyV3-S23	[35]	pFF-BPyV3clone2	AddGene.org	zeo	Re-ligatable bovine polyomavirus 3 isolate 3S23

Adomaviruses
Marbled eel	pMAdO-E	unpublished	pAdOM-E	yes	zeo	Marbled eel adomavirus AclI-EcoRI fragment (early region)
	pMAdO-L	unpublished	pAdOM-L	yes	zeo	Marbled eel adomavirus AclI-EcoRI fragment (late region)
	pMLO1w	unpublished		yes	zeo	Marbled eel adomavirus late ORF expression (EF1alpha promoter)
	pMLO2-3w	unpublished		yes	zeo	Marbled eel adomavirus late ORF expression (EF1alpha promoter)
	pMLO4w	unpublished		yes	zeo	Marbled eel adomavirus late ORF expression (EF1alpha promoter)
	pMLO5w	unpublished		yes	zeo	Marbled eel adomavirus late ORF expression (EF1alpha promoter)
	pMLO6w	unpublished		yes	zeo	Marbled eel adomavirus late ORF expression (EF1alpha promoter)
	pMLO7w	unpublished		yes	zeo	Marbled eel adomavirus late ORF expression (EF1alpha promoter)
	pMLO8w	unpublished		yes	zeo	Marbled eel adomavirus late ORF expression (EF1alpha promoter)

*Plasmids >10kb can be unstable in E. coli.
Growing bacterial starter cultures at 30ºC and/or using Invitrogen STBL2 or Stratagene XL10-Gold bacteria may decrease the risk of plasmid collapse.

1. Buck, C.B., D.V. Pastrana, D.R. Lowy, and J.T. Schiller, Efficient intracellular assembly of papillomaviral vectors.J Virol, 2004. 78(2): p. 751-7.

http://www.ncbi.nlm.nih.gov/pubmed/14694107

2. Roberts, J.N., C.B. Buck, C.D. Thompson, R. Kines, M. Bernardo, P.L. Choyke, D.R. Lowy, and J.T. Schiller, Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan.Nat Med, 2007. 13(7): p. 857-61.

http://www.ncbi.nlm.nih.gov/pubmed/17603495

3. Senger, T., L. Schadlich, S. Textor, C. Klein, K.M. Michael, C.B. Buck, and L. Gissmann, Virus-like particles and capsomeres are potent vaccines against cutaneous alpha HPVs.Vaccine, 2010. 28(6): p. 1583-93.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=20003923

4. Wang, W., C. Wang, S. Xu, C. Chen, X. Tong, Y. Liang, X. Dong, Y. Lei, X. Zheng, J. Yu, and J. Wang, Detection of HPV-2 and identification of novel mutations by whole genome sequencing from biopsies of two patients with multiple cutaneous horns.J Clin Virol, 2007.39(1): p. 34-42.

http://www.ncbi.nlm.nih.gov/pubmed/17368088

5. Faust, H., K. Andersson, O. Forslund, and J. Dillner, Pseudovirion-binding and neutralizing antibodies to cutaneous human papillomaviruses (HPV) correlated with the presence of HPV DNA in skin.J Gen Virol, 2013. 94(Pt 5): p. 1096-103.

https://www.ncbi.nlm.nih.gov/pubmed/23343629

6. Buck, C.B., C.D. Thompson, J.N. Roberts, M. Muller, D.R. Lowy, and J.T. Schiller, Carrageenan is a potent inhibitor of papillomavirus infection.PLoS Pathog, 2006. 2(7): p. e69.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16839203

7. Pastrana, D.V., R. Gambhira, C.B. Buck, Y.Y. Pang, C.D. Thompson, T.D. Culp, N.D. Christensen, D.R. Lowy, J.T. Schiller, and R.B. Roden, Cross-neutralization of cutaneous and mucosal Papillomavirus types with anti-sera to the amino terminus of L2.Virology, 2005. 337(2): p. 365-72.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15885736

8. Mossadegh, N., L. Gissmann, M. Muller, H. Zentgraf, A. Alonso, and P. Tomakidi, Codon optimization of the human papillomavirus 11 (HPV 11) L1 gene leads to increased gene expression and formation of virus-like particles in mammalian epithelial cells.Virology, 2004. 326(1): p. 57-66.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15262495

9. Kieback, E. and M. Muller, Factors influencing subcellular localization of the human papillomavirus L2 minor structural protein.Virology, 2006. 345(1): p. 199-208.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16257028

10. Leder, C., J.A. Kleinschmidt, C. Wiethe, and M. Muller, Enhancement of capsid gene expression: preparing the human papillomavirus type 16 major structural gene L1 for DNA vaccination purposes.J Virol, 2001. 75(19): p. 9201-9.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11533183

11. Buck, C.B. and C.D. Thompson, Production of papillomavirus-based gene transfer vectors.Curr Protoc Cell Biol, 2007. Chapter 26: p. Unit 26.1.

http://www.ncbi.nlm.nih.gov/pubmed/18228512

12. Buck, C.B., N. Cheng, C.D. Thompson, D.R. Lowy, A.C. Steven, J.T. Schiller, and B.L. Trus, Arrangement of L2 within the papillomavirus capsid.J Virol, 2008. 82(11): p. 5190-7.

13. Pastrana, D.V., C.B. Buck, Y.Y. Pang, C.D. Thompson, P.E. Castle, P.C. FitzGerald, S. Kruger Kjaer, D.R. Lowy, and J.T. Schiller, Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18.Virology, 2004. 321(2): p. 205-16.

http://www.ncbi.nlm.nih.gov/pubmed/15051381

14. Kondo, K., Y. Ishii, H. Ochi, T. Matsumoto, H. Yoshikawa, and T. Kanda, Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region.Virology, 2007. 358(2): p. 266-72.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17010405

15. Draper, E., S.L. Bissett, R. Howell-Jones, D. Edwards, G. Munslow, K. Soldan, and S. Beddows, Neutralization of Non-Vaccine Human Papillomavirus Pseudoviruses from the A7 and A9 Species Groups by Bivalent HPV Vaccine Sera.Vaccine, 2011. 29: p. 8585-90.

https://www.ncbi.nlm.nih.gov/pubmed/21939712

16. Faust, H., P. Knekt, O. Forslund, and J. Dillner, Validation of multiplexed human papillomavirus serology using pseudovirions bound to heparin coated beads.J Gen Virol, 2010.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=20181747

17. Kondo, K., H. Ochi, T. Matsumoto, H. Yoshikawa, and T. Kanda, Modification of human papillomavirus-like particle vaccine by insertion of the cross-reactive L2-epitopes.J Med Virol, 2008. 80(5): p. 841-6.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18360909

18. Kwak, K., R. Jiang, J.W. Wang, S. Jagu, R. Kirnbauer, and R.B. Roden, Impact of inhibitors and L2 antibodies upon the infectivity of diverse alpha and beta human papillomavirus types.PLoS One, 2014. 9(5): p. e97232.

http://www.ncbi.nlm.nih.gov/pubmed/24816794

19. Handisurya, A., P.M. Day, C.D. Thompson, C.B. Buck, K. Kwak, R.B. Roden, D.R. Lowy, and J.T. Schiller, Murine skin and vaginal mucosa are similarly susceptible to infection by pseudovirions of different papillomavirus classifications and species.Virology, 2012. 433(2): p. 385-94.

http://www.ncbi.nlm.nih.gov/pubmed/22985477

20. Joh, J., A.B. Jenson, W. King, M. Proctor, A. Ingle, J.P. Sundberg, and S.J. Ghim, Genomic analysis of the first laboratory-mouse papillomavirus.The Journal of general virology, 2011. 92(Pt 3): p. 692-8.

http://www.ncbi.nlm.nih.gov/pubmed/21084500

21. Ingle, A., S. Ghim, J. Joh, I. Chepkoech, A. Bennett Jenson, and J.P. Sundberg, Novel laboratory mouse papillomavirus (MusPV) infection.Vet Pathol, 2011. 48(2): p. 500-5.

http://www.ncbi.nlm.nih.gov/pubmed/20685915

22. Handisurya, A., P.M. Day, C.D. Thompson, C.B. Buck, Y.Y. Pang, D.R. Lowy, and J.T. Schiller, Characterization of Mus musculus Papillomavirus 1 (MusPV1) Infection in Situ Reveals an Unusual Pattern of Late Gene Expression and Capsid Protein Localization.J Virol, 2013. 87(24): p. 13214-25.

23. Nakanishi, A., B. Chapellier, N. Maekawa, M. Hiramoto, T. Kuge, R.U. Takahashi, H. Handa, and T. Imai, SV40 vectors carrying minimal sequence of viral origin with exchangeable capsids.Virology, 2008. 379(1): p. 110-7.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18667220

24. Pastrana, D.V., U. Ray, T.G. Magaldi, R.M. Schowalter, N. Çuburu, and C.B. Buck, BK Polyomavirus Genotypes Represent Distinct Serotypes with Distinct Entry Tropisms.J Virol, 2013. 87(18): p. 10105-13.

http://www.ncbi.nlm.nih.gov/pubmed/23843634

25. Schowalter, R.M., D.V. Pastrana, and C.B. Buck, Glycosaminoglycans and sialylated glycans sequentially facilitate merkel cell polyomavirus infectious entry.PLoS Pathog, 2011. 7(7): p. e1002161.

http://www.ncbi.nlm.nih.gov/pubmed/21829355

26. Zhong, S., P.S. Randhawa, H. Ikegaya, Q. Chen, H.Y. Zheng, M. Suzuki, T. Takeuchi, A. Shibuya, T. Kitamura, and Y. Yogo, Distribution patterns of BK polyomavirus (BKV) subtypes and subgroups in American, European and Asian populations suggest co-migration of BKV and the human race.J Gen Virol, 2009. 90(Pt 1): p. 144-52.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19088283

27. Schowalter, R.M., D.V. Pastrana, K.A. Pumphrey, A.L. Moyer, and C.B. Buck, Merkel Cell Polyomavirus and Two Previously Unknown Polyomaviruses Are Chronically Shed From Human Skin.Cell Host Microbe, 2010. 7(6): p. 509-15.

http://www.ncbi.nlm.nih.gov/pubmed/20542254

28. Buck, C.B., G.Q. Phan, M.T. Raiji, P.M. Murphy, D.H. McDermott, and A.A. McBride, Complete genome sequence of a tenth human polyomavirus.Journal of virology, 2012. 86(19): p. 10887.

http://www.ncbi.nlm.nih.gov/pubmed/22966183

29. Siebrasse, E.A., A. Reyes, E.S. Lim, G. Zhao, R.S. Mkakosya, M.J. Manary, J.I. Gordon, and D. Wang, Identification of MW polyomavirus, a novel polyomavirus in human stool.J Virol, 2012. 86(19): p. 10321-6.

http://www.ncbi.nlm.nih.gov/pubmed/22740408

30. Maginnis, M.S., L.J. Stroh, G.V. Gee, B.A. O'Hara, A. Derdowski, T. Stehle, and W.J. Atwood, Progressive multifocal leukoencephalopathy-associated mutations in the JC polyomavirus capsid disrupt lactoseries tetrasaccharide c binding.MBio, 2013. 4(3): p. e00247-13.

http://www.ncbi.nlm.nih.gov/pubmed/23760462

31. Neumann, F., S. Borchert, C. Schmidt, R. Reimer, H. Hohenberg, N. Fischer, and A. Grundhoff, Replication, Gene Expression and Particle Production by a Consensus Merkel Cell Polyomavirus (MCPyV) Genome.PLoS One, 2011. 6(12): p. e29112.

http://www.ncbi.nlm.nih.gov/pubmed/22216177

32. Tolstov, Y.L., D.V. Pastrana, H. Feng, J.C. Becker, F.J. Jenkins, S. Moschos, Y. Chang, C.B. Buck, and P.S. Moore, Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays.Int J Cancer, 2009.125(6): p. 1250-6.

33. Pastrana, D.V., K.A. Pumphrey, N. Çuburu, R.M. Schowalter, and C.B. Buck, Characterization of monoclonal antibodies specific for the Merkel cell polyomavirus capsid.Virology, 2010. 405(1): p. 20-5.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=20598728

34. Schowalter, R.M. and C.B. Buck, The Merkel cell polyomavirus minor capsid protein.PLoS Pathog, 2013. 9(8): p. e1003558.

http://www.ncbi.nlm.nih.gov/pubmed/23990782

35. Peretti, A., P.C. FitzGerald, V. Bliskovsky, C.B. Buck, and D.V. Pastrana, Hamburger polyomaviruses.J Gen Virol, 2015.

http://www.ncbi.nlm.nih.gov/pubmed/25568187

36. Ray U, Cinque P, Gerevini S, Longo V, Schippling S, Martin R, Buck CB, Pastrana DV: JC Polyomavirus Mutants Escape Antibody-Mediated Neutralization. Science Translational Medicine 2015, 7:306ra151.

https://www.ncbi.nlm.nih.gov/pubmed/29091757